BDBM50438743 CHEMBL2414687

SMILES: C[C@@H]1CN(c2ccc(cc2)[C@H]2CC[C@H](CC(O)=O)CC2)C(=O)c2c(N)ncnc2O1

InChI Key: InChIKey=GYURLMXPLLUHTJ-RBSFLKMASA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50438743   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Diacylglycerol O-acyltransferase 1 (DGAT1) (Homo sapiens (Human))	BDBM50438743 (CHEMBL2414687) Show SMILES C[C@@H]1CN(c2ccc(cc2)[C@H]2CC[C@H](CC(O)=O)CC2)C(=O)c2c(N)ncnc2O1 |r,wU:1.0,10.10,wD:13.14,(24.81,-45.4,;23.9,-44.15,;24.62,-42.79,;23.98,-41.35,;25.01,-40.18,;26.51,-40.48,;27.52,-39.33,;27.01,-37.84,;25.53,-37.59,;24.52,-38.74,;28.04,-36.67,;27.54,-35.23,;28.55,-34.08,;30.06,-34.35,;31.07,-33.19,;32.58,-33.49,;33.07,-34.94,;33.61,-32.31,;30.55,-35.81,;29.54,-36.97,;22.51,-40.98,;22.22,-39.45,;21.26,-41.89,;19.96,-41.07,;20.02,-39.52,;18.59,-41.78,;18.53,-43.33,;19.84,-44.15,;21.21,-43.43,;22.37,-44.44,)| Show InChI InChI=1S/C22H26N4O4/c1-13-11-26(22(29)19-20(23)24-12-25-21(19)30-13)17-8-6-16(7-9-17)15-4-2-14(3-5-15)10-18(27)28/h6-9,12-15H,2-5,10-11H2,1H3,(H,27,28)(H2,23,24,25)/t13-,14-,15-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	19	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry				Bioorg Med Chem 21: 5081-97 (2013) Article DOI: 10.1016/j.bmc.2013.06.045 BindingDB Entry DOI: 10.7270/Q26111RG
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (DGAT1) (Homo sapiens (Human))	BDBM50438743 (CHEMBL2414687) Show SMILES C[C@@H]1CN(c2ccc(cc2)[C@H]2CC[C@H](CC(O)=O)CC2)C(=O)c2c(N)ncnc2O1 |r,wU:1.0,10.10,wD:13.14,(24.81,-45.4,;23.9,-44.15,;24.62,-42.79,;23.98,-41.35,;25.01,-40.18,;26.51,-40.48,;27.52,-39.33,;27.01,-37.84,;25.53,-37.59,;24.52,-38.74,;28.04,-36.67,;27.54,-35.23,;28.55,-34.08,;30.06,-34.35,;31.07,-33.19,;32.58,-33.49,;33.07,-34.94,;33.61,-32.31,;30.55,-35.81,;29.54,-36.97,;22.51,-40.98,;22.22,-39.45,;21.26,-41.89,;19.96,-41.07,;20.02,-39.52,;18.59,-41.78,;18.53,-43.33,;19.84,-44.15,;21.21,-43.43,;22.37,-44.44,)| Show InChI InChI=1S/C22H26N4O4/c1-13-11-26(22(29)19-20(23)24-12-25-21(19)30-13)17-8-6-16(7-9-17)15-4-2-14(3-5-15)10-18(27)28/h6-9,12-15H,2-5,10-11H2,1H3,(H,27,28)(H2,23,24,25)/t13-,14-,15-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	8	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addi...				Bioorg Med Chem 21: 5081-97 (2013) Article DOI: 10.1016/j.bmc.2013.06.045 BindingDB Entry DOI: 10.7270/Q26111RG
					More data for this Ligand-Target Pair